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Introduction
In HIV diagnostics, viral load (VL) measurement is based
on viral RNA. Occasionally, untreated patients present
with a low VL of ≤1000 copies/ml, in which case the VL
may be underestimated. In Switzerland, patients with sus-
pected underestimation of VL by nucleic acid testing
(NAT) are offered VL assessment by the Product
Enhanced Reverse Transcriptase (PERT) assay. Here, we
compared VL measurement by these two methods in
order to assess the frequency and magnitude of NAT-
based VL underestimation.
Material and methods
We compared VL by PERT and NAT for three different
patient groups: (1) newly diagnosed patients with sus-
pected underestimation of VL by NAT (n=19); (2) patients
receiving VL monitoring by PERT based on previously
confirmed underestimation (n=28), and (3) a reference
group of untreated, subtype B-infected patients (n=16).
The output of both assays was copies/ml viral RNA. For
the PERT assay, conversion to copies/ml was based on a
reference correlation of NAT VL and RT-activity (qPCR).
Results
In newly diagnosed patients approximately 4% have a sus-
pected VL underestimation by NAT (≤1000 copies/ml).
PERT results were available for 19 of 59 of such newly
diagnosed patients (32.2%). The median difference (log
copies/ml) between PERT and NAT VL for this group was
1.36, compared to 0.92 for PERT-monitored patients and
-0.004 for the reference group. In 74% of newly diagnosed
and 68% of PERT-monitored patients the VL by PERT
was ≥5x higher compared to NAT (reference group: 0%).
Correlation between PERT and NAT was at R2=0.02 for
newly diagnosed patients, 0.63 for PERT-monitored
patients and 0.89 for the reference group. Patient groups
(1) and (2) both comprised a mixture of subtypes, includ-
ing subtype B.
Conclusions
This analysis confirms that VL underestimation still
occasionally occurs, even with the improved contempor-
ary VL tests. Causes include sequence variations leading
to impaired primer/probe-binding during cDNA amplifi-
cation. As inadvertent VL underestimation may lead to
further infections or inappropriate treatment decisions,
a sequence-independent test, like the PERT, remains
valuable for confirming a low VL.
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